Feb 27 (Reuters) - Endo Pharmaceuticals Holdings Inc posted a 48 percent rise in quarterly profit, above analysts’ estimates, helped partly by higher sales of pain drug Opana and generic products.
Feb 27 (Reuters) - Endo Pharmaceuticals Holdings Inc posted a 48 percent rise in quarterly profit, above analysts’ estimates, helped partly by higher sales of pain drug Opana and generic products.
